Pediatric Type 1 Diabetes: Is Age at Onset a Determining Factor in Advanced Hybrid Closed-Loop Insulin Therapy?
Alfonso Lendínez-JuradoJuan Pedro López-SigueroAna Gómez-PereaAna-Belen Ariza-JimenezIcía Becerra-PazLeopoldo Tapia-CeballosCarmen Cruces-PonceJosé Manuel Jiménez-HinojosaSonsoles MorcilloIsabel Leiva-GeaPublished in: Journal of clinical medicine (2023)
780G system brings glucometric results closer to those recommended by consensus, especially in age at T1D onset >4 years. However, the management in pediatrics continues to be a challenge even after the implementation of these systems, especially in terms of hyperglycemia and glycemic variability.